2m 2m 2m 2m 2m 2m 2m
Collegium Pharma (COLL)
NASDAQ
$34.82-$0.005 (-0.01%)
Price as of Jul 14, 2026 4:08 AM EDT- $1.1BMarket Cap
- 6.06%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Collegium Pharma (COLL)
$34.82-$0.005 (-0.01%)
COLL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $34.82 | ||
Change | -$0.41 (-1.16%) | ||
Open | $35.15 | ||
High | $35.53 | ||
Low | $34.65 | ||
Previous Close | $35.23 | ||
Volume | 343,220 | ||
30-Day Average Volume | 476,676 | ||
1-Week Change | -7.07% | ||
1-Month Change | 0.52% | ||
1-Year Change | 6.06% | ||
3-Year Change | 64.01% | ||
5-Year Change | 48.17% | ||
Fundamentals | |||
Shares Outstanding | 32.4M | ||
Total Assets | $1.7B | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $193.5M | ||
Net Income | $14.5M | ||
Free Cash Flow | $56.8M | ||
EBIT | $28.8M | ||
EBITDA | $84.2M | ||
Net Working Capital | $310.7M | ||
EPS | $0.40 | ||
Enterprise Value/EBITDA | 20 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 4 | ||
P/E | 87 | ||
PEG | 8 | ||
Price/Free Cash Flow | 20 | ||
Price/Operating Cash Flow | 20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue